Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02697799 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Recruitment Strategies for Research Participation
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,296
- Enrollment target
NCT02697799: Completed NA study, sponsored by University of Pennsylvania.
NCT02697799 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,296 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02697799, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,296 participants
- Enrollment target
Study Summary
In a multicenter, randomized clinical trial of attitudes towards research participation, we will evaluate the ethics, effectiveness, and cost- effectiveness of three recruitment strategies for research participation in a mobility trial among hospitalized patients and a smoking cessation trial among patients with depression.
Primary Outcome
Consent rates in each of the two parent RCTs
Interventions
- BEHAVIORAL High-level recruitment strategy consent form
- BEHAVIORAL Mid-level recruitment strategy consent form
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,296 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
What the finished NCT02697799 record still lists
NCT02697799 is an interventional study that assigns participants to a tested intervention. Its 1,296 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which High-level recruitment strategy consent form is the first listed.
NCT02697799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02697799 about?
NCT02697799 is a clinical study titled "A Randomized Trial of Recruitment Strategies for Research Participation". In a multicenter, randomized clinical trial of attitudes towards research participation, we will evaluate the ethics, effectiveness, and cost- effectiveness of three recruitment strategies for research participation in a mobility trial among hospitalized patients and a smoking cessation trial among ...
What is the current status of trial NCT02697799?
This trial is currently completed. It is a NA study. The enrollment target is 1,296 participants. The study started on 2016-08. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT02697799?
The interventions under investigation include: High-level recruitment strategy consent form (BEHAVIORAL), Mid-level recruitment strategy consent form (BEHAVIORAL).
Who is sponsoring clinical trial NCT02697799?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02697799's enrollment target sits among peer trials
1,296 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia